Bexson Biomedical Closes $4.8M Series A Financing To Develop Wearable Ketamine Technology
Pharmaceutical startup Bexson Biomedical confirmed Monday the closing an oversubscribed Series A funding round. The $4.8
Pharmaceutical startup Bexson Biomedical confirmed Monday the closing an oversubscribed Series A funding round. The $4.8